IMPAACT 2001: Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection

Post Date: 
2017-05-30
Summary: 

Invited presenter. Tuberculosis Scientific Committee.

Presentation Location: 
Washington, DC
Event & Convener: 
2017 IMPAACT Annual Meeting